ICET, Inc. has a substantial history of innovation in most of today's major markets. We have done several projects for all branches of the Army, Navy, Environmental Protection Agency, Department of Energy and several with National Institutes of Health and have developed useful products. Has generated 6.5 million in sales of R&D services and custom products -Beverage companies, clothing industry, specialty medical device coatings, fuel cell catalysts, environmental applications and water treatment. 8 Patents including an international Patent with 6 patents pending.

Unique, Proprietary Silver Accentuating Chemistry

• ICET synergistic formulation provides a triple defense mechanism against bacterial and fungal microbial biofilms and prevents calcium and magnesium deposits.
• No known microbial resistance for silver, safe history, easier FDA approval process.
• Maintaining wetting with lubrication allows sustained diffusion of silver species and synergistic agents.
• Adjustable sustained long term release that can be incorporated into polymeric coatings and extrudable plastics.

ICET Advantage :

• Key advantage, safety history of silver accepted by FDA.
• Antiseptic like chlrohexidine, triclosan, Nitrofurazone cause mucosal irritation and hypersensitivity; antibiotics coatings last only for short periods and the risk for the selection of resistance exists.
• ICET is currently an R&D company that is transitioning into a manufacturing company.
• ICET works with several manufacturing partners. They provide vendor services to ICET.

Antimicrobial coated catheters are an attractive solution for Infection prevention in short term use (less than 7 days) and to date the only two major silver based Foley catheters in the market have not shown much clinical promise, though silver is an excellent biocide, with a good safety history, used in various medical devices for successful infection control (FDA CDRH data base). Rather than cast doubt on the efficacy of silver as a biocide based on the one type of Foley catheter type evaluated, many clinicians and the FDA believe that NOT all silver products are the same; the efficacy depends on the continuous delivery mechanism of silver from the coating on the surface and that clinical trials of new silver-coated urological products remain critically important. Our product TIC is not “yet another silver catheter” but may prove to be a cut above the rest.

Protective Materials : ICET is playing the lead role in combining its CB protective technology with the special fabrics and to provide integrated highly breathable air permeable and impermeable fabric composites with significant comfort, highly reduced thermal burden, CB , Toxic Industrial Chemical protection, ( active and passive) FR, DWR and nIR features. Added features are novel moisture transport, odor absorption and lightweight materials.

Water Treatment : Through cooperative efforts between the MWRA ( Mass Water Resources Authority) and the state funded STEP (Strategic Enviro-Partnership) program, a pilot demonstration at two sites—one a large hospital and another a research institution—was successfully completed. The challenge to the participating vendors was to operate a pilot unit continuously for 6-to-8 weeks at these facilities and achieve less than 1 ppb levels of mercury discharged from these complex wastewaters.

ICET sorbent surpassed providing consistently below 0.2ppb in the treated effluent, even when large spikes of mercury occurred. The media was also found resistant to biofouling.